The deal range was $23.00-$23.50. Jefferies and Piper Sandler acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NKTR:
- Nektar 4.255M share Spot Secondary priced at $23.00.50
- Closing Bell Movers: Progress Software slips 4% after earnings
- Nektar announces common stock offering, no amount given
- Nektar Therapeutics Regains Nasdaq Compliance by June 2025
- Nektar Therapeutics’ Phase 2b Study on Rezpegaldesleukin: A Potential Game-Changer for Atopic Dermatitis